Scenario drafting to anticipate future developments in technology assessment

by Retèl, Valesca P, Joore, Manuela A, Linn, Sabine C, Rutgers, Emiel JT, van Harten, Wim H
Published 2012

Association between genomic recurrence risk and well-being among breast cancer patients

by Retèl, Valesca P, Groothuis-Oudshoorn, Catharina GM, Aaronson, Neil K, Brewer, Noel T, Rutgers, Emiel JT, van Harten, Wim H
Published 2013

Next-generation sequencing in NSCLC and melanoma patients: a cost and budget impact analysis

by van Amerongen, Rosa A, Retèl, Valesca P, Coupé, Veerle MH, Nederlof, Petra M, Vogel, Maartje J, van Harten, Wim H
Published 2016

Exploratory Cost-Effectiveness Analysis of Response-Guided Neoadjuvant Chemotherapy for Hormone Positive Breast Cancer Patients

by Miquel-Cases, Anna, Retèl, Valesca P., Lederer, Bianca, von Minckwitz, Gunter, Steuten, Lotte M. G., van Harten, Wim H.
Published 2016

Determinants and effects of positive surgical margins after prostatectomy on prostate cancer mortality: a population-based study

by Retèl, Valesca P, Bouchardy, Christine, Usel, Massimo, Neyroud-Caspar, Isabelle, Schmidlin, Franz, Wirth, Gregory, Iselin, Christophe, Miralbell, Raymond, Rapiti, Elisabetta
Published 2014

A cost-effectiveness analysis of a preventive exercise program for patients with advanced head and neck cancer treated with concomitant chemo-radiotherapy

by Retèl, Valesca P, van der Molen, Lisette, Hilgers, Frans JM, Rasch, Coen RN, L'Ortye, Annemiek AAMHJ, Steuten, Lotte MG, van Harten, Wim H
Published 2011